120 related articles for article (PubMed ID: 9883811)
21. The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphoma
.
Yasu T; Kobayashi S; Horii M; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Dec; 54(12):1009-1012. PubMed ID: 27641217
[TBL] [Abstract][Full Text] [Related]
22. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
[TBL] [Abstract][Full Text] [Related]
23. Calcification of the gastric mucosa associated with tumor lysis syndrome in a child with non-Hodgkin lymphoma.
Avci Z; Alioglu B; Canan O; Ozcay F; Celasun B; Sarialioglu F; Ozbek N
J Pediatr Hematol Oncol; 2006 May; 28(5):307-10. PubMed ID: 16772882
[TBL] [Abstract][Full Text] [Related]
24. ARDS associated with tumor lysis syndrome in a patient with non-Hodgkin's lymphoma.
Marenco JP; Nervi A; White AC
Chest; 1998 Feb; 113(2):550-2. PubMed ID: 9498984
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
[TBL] [Abstract][Full Text] [Related]
26. Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.
Wang LY; Shih LY; Chang H; Jou ST; Lin KH; Yeh TC; Lin SF; Liang DC
Acta Haematol; 2006; 115(1-2):35-8. PubMed ID: 16424647
[TBL] [Abstract][Full Text] [Related]
27. Fludarabine-induced tumour lysis in low-grade non-Hodgkin's lymphoma.
Killick S; Mercieca J; Nandi A; Behrens J
Clin Lab Haematol; 1997 Mar; 19(1):79-80. PubMed ID: 9146954
[No Abstract] [Full Text] [Related]
28. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
[TBL] [Abstract][Full Text] [Related]
29. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
[TBL] [Abstract][Full Text] [Related]
30. [B-cell non-Hodgkin's lymphoma associated with lactic acidosis, recurrent acute tumor lysis syndrome, and at the end stage, Guillain-Barré syndrome].
Kurata H; Hirai M; Miwa A; Murai Y; Mori M
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1765-70. PubMed ID: 2625598
[No Abstract] [Full Text] [Related]
31. [Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
Nielsen SH; Hasselbalch HC; Birgens HS
Ugeskr Laeger; 1991 Oct; 153(42):2952-3. PubMed ID: 1949322
[TBL] [Abstract][Full Text] [Related]
32. Carfilzomib-associated tumor lysis syndrome.
Shely RN; Ratliff PD
Pharmacotherapy; 2014 May; 34(5):e34-7. PubMed ID: 24390940
[TBL] [Abstract][Full Text] [Related]
33. Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy.
McAfee SL; Powell SN; Colby C; Spitzer TR
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):151-6. PubMed ID: 12007954
[TBL] [Abstract][Full Text] [Related]
34. Acute spontaneous tumor lysis syndrome in a patient with Crohn's disease taking immunosuppressants.
Froilán Torres C; Castro Carbajo P; Pajares Villarroya R; Plaza Santos R; Gómez Senent S; Martín Arranz MD; Adán Merino L; Martín Arranz E; Manceñido Marcos N; Peces R; Benito López D
Rev Esp Enferm Dig; 2009 Apr; 101(4):288-94. PubMed ID: 19492906
[TBL] [Abstract][Full Text] [Related]
35. Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries.
Annemans L; Moeremans K; Lamotte M; Garcia Conde J; van den Berg H; Myint H; Pieters R; Uyttebroeck A
Leuk Lymphoma; 2003 Jan; 44(1):77-83. PubMed ID: 12691145
[TBL] [Abstract][Full Text] [Related]
36. Alkalinization and the tumor lysis syndrome.
Ten Harkel AD; Kist-Van Holthe JE; Van Weel M; Van der Vorst MM
Med Pediatr Oncol; 1998 Jul; 31(1):27-8. PubMed ID: 9607427
[No Abstract] [Full Text] [Related]
37. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
[TBL] [Abstract][Full Text] [Related]
38. [A case of esophageal cancer patient who developed tumor lysis syndrome after chemotherapy].
Tokunou K; Takeda S; Yoshino S; Nishimura T; Oka M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2030-2. PubMed ID: 19106513
[TBL] [Abstract][Full Text] [Related]
39. Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.
Vines AN; Shanholtz CB; Thompson JL
Ann Pharmacother; 2010 Oct; 44(10):1529-37. PubMed ID: 20841516
[TBL] [Abstract][Full Text] [Related]
40. Acute tumor lysis syndrome in high grade lymphoblastic lymphoma after a prolonged episode of fever.
Levin M; Cho S
Med Pediatr Oncol; 1996 Jun; 26(6):417-8. PubMed ID: 8614380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
